{"precision": 0.625, "recall": 0.7142857142857143, "macro_F1": 0.6666666666666666, "micro_F1": 0.6666666666666666, "accuracy": 0.6666666666666666, "correct_cases": {"1228": {"text": "OBJECTIVES : To describe clinical and pathologic findings in patients noted to develop lower gastrointestinal symptoms when exposed to rofecoxib .", "true": [["lower gastrointestinal symptoms", "rofecoxib"]], "pred": [["lower gastrointestinal symptoms", "rofecoxib"]], "response": " [['lower gastrointestinal symptoms', 'rofecoxib']]\nExplanation: Patients exposed to rofecoxib developed lower gastrointestinal symptoms."}, "2384": {"text": "Severe cardiomyopathy following treatment with the tumour necrosis factor - alpha inhibitor adalimumab for Crohn 's disease .", "true": [["severe cardiomyopathy", "adalimumab"]], "pred": [["severe cardiomyopathy", "adalimumab"]], "response": " [['Severe cardiomyopathy', 'adalimumab']]\nExplanation: Treatment with adalimumab caused severe cardiomyopathy in a patient with Crohn's disease."}, "1528": {"text": "Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C -- a case report and review of the literature .", "true": [["sarcoidosis", "interferon alpha 2b"], ["sarcoidosis", "ribavirin"]], "pred": [["sarcoidosis", "interferon alpha 2b"], ["sarcoidosis", "ribavirin"]], "response": " [['sarcoidosis', 'interferon alpha 2b'], ['sarcoidosis', 'ribavirin']]\nExplanation: Interferon alpha 2b and ribavirin combination therapy can cause sarcoidosis in patients with chronic hepatitis C."}, "3323": {"text": "The probability of developing acute leukemia in this study was not significantly correlated to the total cumulative dosage of Treosulfan .", "true": [["acute leukemia", "treosulfan"]], "pred": [["acute leukemia", "treosulfan"]], "response": " [['acute leukemia', 'Treosulfan']]\nExplanation: The study showed no significant correlation between total cumulative dosage of Treosulfan and the development of acute leukemia."}}, "fail_cases": {"3734": {"text": "Phenytoin toxicity due to concomitant antituberculosis therapy .", "true": [["phenytoin toxicity", "phenytoin"]], "pred": [["phenytoin toxicity", "antituberculosis therapy"]], "response": " [['Phenytoin toxicity', 'antituberculosis therapy']]\nExplanation: Antituberculosis therapy caused phenytoin toxicity."}, "979": {"text": "2-Chloro - deoxyadenosine induces durable complete remission in Castleman 's disease but may accelerate its transformation to non - Hodgkin 's lymphoma .", "true": [["non - hodgkin \"s lymphoma", "2-chloro - deoxyadenosine"]], "pred": [["durable complete remission", "2-chloro - deoxyadenosine"], ["accelerate its transformation to non - hodgkin \"s lymphoma", "2-chloro - deoxyadenosine"]], "response": " [['durable complete remission', '2-Chloro - deoxyadenosine'], ['accelerate its transformation to non - Hodgkin \\'s lymphoma', '2-Chloro - deoxyadenosine']]\nExplanation: 2-Chloro-deoxyadenosine induced both durable complete remission and accelerated transformation to non-Hodgkin's lymphoma in Castleman's disease."}}, "missing_cases": {"3734": [["phenytoin toxicity", "phenytoin"]], "979": [["non - hodgkin \"s lymphoma", "2-chloro - deoxyadenosine"]]}, "false_cases": {"3734": [["phenytoin toxicity", "antituberculosis therapy"]], "979": [["accelerate its transformation to non - hodgkin \"s lymphoma", "2-chloro - deoxyadenosine"], ["durable complete remission", "2-chloro - deoxyadenosine"]]}}